• 1
    Baum JK, Holtz F, Bookstein JJ, Klein EW. Possible association between benign hepatomas and oral contraceptives. Lancet 1973; 2: 926929.
  • 2
    Barbour J, Henry the Minstrel. The Bruce and Wallace; published from two ancient manuscripts preserved in the Library of the Faculty of Advocates with notes, biographical sketches, and a glossary. JamiesonJ, ed. Glasgow, UK: Maurice Ogle and Co., 1889.
  • 3
    Barbour J. The Bruce. Eyre-Todd G (trans.). Edinburgh, UK: Mercat Press, 1996.
  • 4
    Churchill WS. A history of the English-speaking peoples. Vol. 1. The birth of Britain, 3rd Edition. London, UK: Cassell and Company, Ltd., 1956; 242.
  • 5
    Djerassi C. The pill, pygmy chimps, and Degas' horse. New York, NY: Basic Books, 1992.
  • 6
    Colton FB. Steroids and “the pill”: early steroid research at Searle. Steroids 1992; 57: 624630.
  • 7
    Pincus G, Garcia CR, Rock J, Paniagua M, Pendleton A, Laraque F, et al. Effectiveness of an oral contraceptive; effects of a progestin-estrogen combination upon fertility, menstrual phenomena, and health. Science 1959; 130: 8183.
  • 8
    Watkins ES. On the pill: A social history of oral contraceptives 1950-1970. Baltimore, MD: Johns Hopkins University Press, 1998.
  • 9
    Tsung SH, Loh WP. A Review: adverse effects of oral contraceptives. J Indiana State Med Assoc 1979; 72: 578580.
  • 10
    Seaman B. The doctor's case against the pill. Almeda, CA: Hunter House Publishers, 1995.
  • 11
    Lee L. Bad predictions. Rochester Hills, MI: Elsewhere Press, 2000.
  • 12
    Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology 1977; 73: 386394.
  • 13
    Kay S, Shatzki PF. Ultrastructure of a benign liver cell adenoma. Cancer 1971; 28: 755762.
  • 14
    Horvath E, Kovacs K, Ross RC. Ultrastructural findings in a well-differentiated hepatoma. Digestion 1972; 7: 7482.
  • 15
    Editorial. A few women taking the Pill found to have benign liver tumors. JAMA 1975; 231: 451452.
  • 16
    Baum JK. Liver tumors and oral contraceptives. JAMA 1975; 231: 1329.
  • 17
    Berkheiser SW. Recurrent liver cell adenoma. Gastroenterology 1959: 37: 760765.
  • 18
    Henson Jr.SW, Gray HK, Dockerty MB. Benign tumors of the liver. I. Adenomas. Surg Gynecol Obstet 1956; 103: 2330.
  • 19
    Warvi WN. Primary neoplasms of the liver. Arch Pathol 1944; 37: 367382.
  • 20
    Nissen ED, Kent DR, Nissen SE. Role of oral contraceptive agents in the pathogenesis of liver tumors. J Toxicol Environ Health 1979; 5: 231254.
  • 21
    Mays ET, Christopherson W. Hepatic tumors induced by sex steroids. Semin Liver Dis 1984; 4: 147157.
  • 22
    Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997; 24: 276279.
  • 23
    Lee PJ. Glycogen storage disease type I: pathophysiology of liver adenomas. Eur J Pediatr 2002; 161(Suppl): S46S49.
  • 24
    Lack EE, Ornvold K. Focal nodular hyperplasia and hepatic adenomas: a review of eight cases in the pediatric age group. J Surg Oncol 1986; 33: 129135.
  • 25
    Wheeler DA, Edmondson HA, Reynolds TB. Spontaneous liver cell adenoma in children. Am J Clin Pathol 1986; 85: 612.
  • 26
    Karhunen PJ, Penttilä A, Liesto K, Männikkö A, Möttönen MM. Occurrence of benign hepatocellular tumors in alcoholic men. Acta Pathol Microbiol Immunol Scand [A] 1986; 94: 141147.
  • 27
    Touraine RL, Bertrand Y, Foray P, Gilly J, Phillippe N. Hepatic tumours during androgen therapy in Fanconi anæmia. Eur J Pediatr 1993; 152: 691693.
  • 28
    Nakao A, Sakagami K, Nakata Y, Komazawa K, Amimoto T, Nakashima K, et al. Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis. J Gastroenterol 2000; 35: 557562.
  • 29
    Carrasco D, Prieto M, Pallardo L, Moll JL, Cruz JM, Munoz C, et al. Multiple hepatic adenomas after long-term therapy with testosterone enanthate: review of the literature. J Hepatol 1985; 1: 573578.
  • 30
    Grangé JD, Guéchot J, Legendre C, Giboudeau J, Darnis F, Poupon R. Liver adenoma and focal nodular hyperplasia in a man with high endogenous sex steroids. Gastroenterology 1987; 93: 14091413.
  • 31
    Espat J, Chamberlain RS, Sklar C, Blumgart LH. Hepatic adenoma associated with recombinant growth hormone therapy in a patient with Turner's syndrome. Dig Surg 2000; 17: 640643.
  • 32
    Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, et al. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 1997; 21: 983990.
  • 33
    Adlercreutz H, Tenhunen R. Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am J Med 1970; 49: 630648.
  • 34
    Sherlock S. Progress Report. Hepatic adenomas and oral contraceptives. Gut 1975; 16: 753756.
  • 35
    Dourakis SP, Tolis G. Sex hormonal preparations and the liver. Eur J Contracept Reprod Health Care 1998; 3: 716.
  • 36
    Naeem M, Schenker S. Adverse effects of hormones and hormone antagonists on the liver. In: KaplowitzN, DeLeveLD, eds. Drug-induced Liver Disease. New York, NY: Marcel Dekker Inc., 2003; 677708.
  • 37
    Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, et al. The cooperative liver tumor study group. Epidemiology of hepatocellular adenoma: the role of oral contraceptive use. JAMA 1979; 242: 644648.
  • 38
    Bühler H, Pirovino M, Akovbiantz A, Altorfer J, Weitzel M, Maranta E, et al. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 1982; 82: 775782.
  • 39
    Mariani AF, Livingstone AS, Pereiras RV Jr, van Zuiden PE, Schiff ER. Progressive enlargement of an hepatic cell adenoma. Gastroenterology 1979; 77: 13191325.
  • 40
    Gyorffy EJ, Bredfeldt JE, Black WC. Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use. Ann Intern Med 1989; 110: 489490.
  • 41
    Porter LE, Van Thiel DH, Eagon PK. Estrogens and progestins as tumor inducers. Semin Liver Dis 1987; 7: 2431.
  • 42
    Cohen C, Lawson D, DeRose PB. Sex and androgenic steroid receptor expression in hepatic adenomas. Hum Pathol 1998; 29: 14281432.
  • 43
    Torbenson M, Lee JH, Choti M, Gage W, Abraham SC, Montgomery E, et al. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway. Mod Pathol 2002; 15: 189196.
  • 44
    Benhamou JP. Diagnostic approach to a liver mass: diagnosis of an asymptomatic liver tumor in a young woman. J Hepatol 1996; 25(Suppl): 3034.